Abstract

Inhibition of DNA binding proteins 1 and 3 (ID1 and ID3) are important downstream targets of BMP signalling that are necessary for embryonic development. However, their specific roles in regulating the pluripotency of human embryonic stem cells (hESCs) remain unclear. Here, we examined the roles of ID1 and ID3 in primed and naive-like hESCs and showed that ID1 and ID3 knockout lines (IDs KO) exhibited decreased survival in both primed and naive-like state. IDs KO lines in the primed state also tended to undergo pluripotent dissolution and ectodermal differentiation. IDs KO impeded the primed-to-naive transition (PNT) of hESCs, and overexpression of ID1 in primed hESCs promoted PNT. Furthermore, single-cell RNA sequencing demonstrated that ID1 and ID3 regulated the survival and pluripotency of hESCs through the AKT signalling pathway. Finally, we showed that TCF3 mediated transcriptional inhibition of MCL1 promotes AKT phosphorylation, which was confirmed by TCF3 knockdown in KO lines. Our study suggests that IDs/TCF3 acts through AKT signalling to promote survival and maintain pluripotency of both primed and naive-like hESCs.

Details

Title
ID proteins promote the survival and primed-to-naive transition of human embryonic stem cells through TCF3-mediated transcription
Author
Jiang, Haibin 1 ; Du, Mingxia 2 ; Li, Yaning 3 ; Zhou, Tengfei 4 ; Lei, Jia 3 ; Liang, Hongqing 5 ; Zhong, Zhen 6 ; Al-Lamki, Rafia S. 7 ; Jiang, Ming 8 ; Yang, Jun 3   VIAFID ORCID Logo 

 Peking Union Medical College, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Beijing, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839); Zhejiang University School of Medicine, Hangzhou, Department of Physiology and Department of Cardiology of the Second Affiliated Hospital, Zhejiang, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X) 
 Peking Union Medical College, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Beijing, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839) 
 Zhejiang University School of Medicine, Hangzhou, Department of Physiology and Department of Cardiology of the Second Affiliated Hospital, Zhejiang, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X) 
 The First Affiliated Hospital of Wenzhou Medical University, Department of Pulmonary and Critical Care Medicine, Wenzhou, China (GRID:grid.414906.e) (ISNI:0000 0004 1808 0918) 
 Zhejiang University School of Medicine, Division of Human Reproduction and Developmental Genetics, Women’s Hospital and Institute of Genetics, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X) 
 Zhejiang University School of Medicine, Department of human anatomy and histoembryology, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X) 
 University of Cambridge, Department of Medicine, National Institute of Health Research Cambridge Biomedical Research Centre, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934) 
 Department of Gastroenterology of The Children’s Hospital, Institute of Genetics, Zhejiang University School of Medicine, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X) 
Publication year
2022
Publication date
Jun 2022
Publisher
Springer Nature B.V.
e-ISSN
20414889
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2676408285
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.